Global Nuclear Imaging Market 2017-2021
|発行||TechNavio (Infiniti Research Ltd.)||商品コード||325829|
|出版日||ページ情報||英文 117 Pages
|核画像の世界市場：2017年〜2021年 Global Nuclear Imaging Market 2017-2021|
|出版日: 2017年08月09日||ページ情報: 英文 117 Pages||
Nuclear imaging is a branch of medical imaging which uses small amounts of radioactive tracers to diagnose, to determine severity of the disease, and treat various chronic disorders such as cancers, cardiac diseases, gastrointestinal and neurological abnormalities. PET nuclear imaging has multiple applications in clinical neurology, includes epilepsy, movement disorders, brain tumors, dementia, neuronal plasticity, and stroke. Also, it is used to diagnose oncology, cardiology (has some limited applications), and other neurodegenerative disorders. However, the majority of PET scans are used to diagnose and treat cancers. The radioactive tracers concentrate in the regions of cancer, which are detected by the PET nuclear imaging.
Technavio's analysts forecast the global nuclear imaging market to grow at a CAGR of 6.01% during the period 2017-2021.
The report covers the present scenario and the growth prospects of the global nuclear imaging market for 2017-2021. To calculate the market size, the report considers the revenue generated form the new nuclear imaging equipment sales.
The market is divided into the following segments based on geography:
Technavio's report, Global Nuclear Imaging Market 2017-2021 has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.